Prevalence of OSA in Patients of ILD

Pattern Of Association Between Obstructive Seep Apnea and Interstitial Lung Disease

To evaluate the clinical predictors of OSA in patients with ILD

Study Overview

• Status: Not yet recruiting
• Conditions: OSA

Detailed Description

Interstitial lung diseases (ILDs) are a group of heterogeneous disorders characterized by varying degrees of fibrosis and inflammation of lung parenchyma.

Obstructive sleep apnea is a type of sleep disordered breathing characterized by repeated episodes of apnea and hypopnea during sleep due to narrowing or occlusion of the upper airway.

It was found that the prevalence of OSA is as high as 80% among patients with idiopathic pulmonary fibrosis (IPF). Despite this common association, there is limited research in this field. There is great need for further studies to highlight this association and understand the underlying pathophysiological mechanisms implicated in those patients, to ultimately guide the appropriate management.

• Study Type: Observational
• Enrollment (Estimated): 81

Contacts and Locations

• Study Contact: Name: Hend saleh, MD; Phone Number: 01098988712; Email: hend.m.saleh@gmail.com
• Study Contact Backup: Name: Mohamed Khalaf, MD; Phone Number: 01026600071; Email: dr.mga2011@aun.edu.eg

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patients admitted to Assiut University Hospital diagnosed as interstitial lung disease risky for OSA will be included from June 2023 to January 2024.

Description

Inclusion Criteria:

• Patients presented to Chest Department with interstitial lung disease will be included, screened for OSA.

Exclusion Criteria:

• Age: less than 18 years. Unstable patients or need for ICU admission

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Predictors of OSA in patients with ILD	By clinical history ,examination, BMI	Baseline

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Prevalence of OSA among patients with ILD Presented To Chest Department in Assiut University Hospital	BY Polysomnography	base line

Collaborators and Investigators

• Sponsor: Assiut University
• Investigators: Study Chair: Mohamed yassen, MD, Assiut University

Study record dates

Study Major Dates

• Study Start (Estimated): October 20, 2023
• Primary Completion (Estimated): September 28, 2024
• Study Completion (Estimated): December 25, 2024

Study Registration Dates

• First Submitted: September 22, 2023
• First Submitted That Met QC Criteria: September 22, 2023
• First Posted (Actual): September 28, 2023

Study Record Updates

• Last Update Posted (Actual): September 28, 2023
• Last Update Submitted That Met QC Criteria: September 22, 2023
• Last Verified: April 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: ILD,OSA

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No